annual retained earnings:
$359.87M+$269.32M(+297.43%)Summary
- As of today (June 22, 2025), HALO annual retained earnings is $359.87 million, with the most recent change of +$269.32 million (+297.43%) on December 31, 2024.
- During the last 3 years, HALO annual retained earnings has risen by +$418.78 million (+710.86%).
- HALO annual retained earnings is now at all-time high.
Performance
HALO Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$477.96M+$118.09M(+32.82%)Summary
- As of today (June 22, 2025), HALO quarterly retained earnings is $477.96 million, with the most recent change of +$118.09 million (+32.82%) on March 31, 2025.
- Over the past year, HALO quarterly retained earnings has increased by +$310.59 million (+185.57%).
- HALO quarterly retained earnings is now at all-time high.
Performance
HALO quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
HALO Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +297.4% | +185.6% |
| 3 y3 years | +710.9% | +10000.0% |
| 5 y5 years | +159.6% | +178.4% |
HALO Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +710.9% | at high | >+9999.0% |
| 5 y | 5-year | at high | +159.6% | at high | +178.4% |
| alltime | all time | at high | +159.6% | at high | +173.7% |
HALO Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $477.96M(+32.8%) |
| Dec 2024 | $359.87M(+297.4%) | $359.87M(-9.5%) |
| Sep 2024 | - | $397.63M(+52.6%) |
| Jun 2024 | - | $260.62M(+55.7%) |
| Mar 2024 | - | $167.37M(+84.8%) |
| Dec 2023 | $90.55M(-36.8%) | $90.55M(-59.3%) |
| Sep 2023 | - | $222.28M(+58.3%) |
| Jun 2023 | - | $140.45M(+113.8%) |
| Mar 2023 | - | $65.69M(-54.1%) |
| Dec 2022 | $143.22M(-343.1%) | $143.22M(+67.5%) |
| Sep 2022 | - | $85.52M(+258.1%) |
| Jun 2022 | - | $23.88M(+1896.7%) |
| Mar 2022 | - | $1.20M(-102.0%) |
| Dec 2021 | -$58.91M(-87.6%) | -$58.91M(-53.1%) |
| Sep 2021 | - | -$125.68M(-63.3%) |
| Jun 2021 | - | -$342.27M(-21.1%) |
| Mar 2021 | - | -$433.73M(-8.6%) |
| Dec 2020 | -$474.59M(-21.4%) | -$474.59M(-13.4%) |
| Sep 2020 | - | -$547.76M(-6.2%) |
| Jun 2020 | - | -$583.96M(-4.2%) |
| Mar 2020 | - | -$609.78M(+1.0%) |
| Dec 2019 | -$603.68M(+13.6%) | -$603.68M(+6.0%) |
| Sep 2019 | - | -$569.28M(+4.6%) |
| Jun 2019 | - | -$544.27M(+2.8%) |
| Mar 2019 | - | -$529.64M(-0.3%) |
| Dec 2018 | -$531.44M(+1.7%) | -$531.44M(+0.4%) |
| Sep 2018 | - | -$529.31M(+5.6%) |
| Jun 2018 | - | -$501.46M(+4.8%) |
| Mar 2018 | - | -$478.57M(-8.4%) |
| Dec 2017 | -$522.37M(-10.8%) | -$522.37M(-19.2%) |
| Sep 2017 | - | -$646.25M(-0.4%) |
| Jun 2017 | - | -$649.00M(+5.0%) |
| Mar 2017 | - | -$618.24M(+5.6%) |
| Dec 2016 | -$585.34M(+21.3%) | -$585.34M(+4.9%) |
| Sep 2016 | - | -$557.96M(+5.5%) |
| Jun 2016 | - | -$529.01M(+5.4%) |
| Mar 2016 | - | -$502.13M(+4.0%) |
| Dec 2015 | -$482.66M(+7.2%) | -$482.66M(-0.9%) |
| Sep 2015 | - | -$486.98M(+5.3%) |
| Jun 2015 | - | -$462.52M(-0.6%) |
| Mar 2015 | - | -$465.54M(+3.4%) |
| Dec 2014 | -$450.43M(+17.9%) | -$450.43M(+1.2%) |
| Sep 2014 | - | -$445.15M(+4.8%) |
| Jun 2014 | - | -$424.87M(+4.0%) |
| Mar 2014 | - | -$408.60M(+6.9%) |
| Dec 2013 | -$382.05M | -$382.05M(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -$360.07M(+5.7%) |
| Jun 2013 | - | -$340.77M(+7.2%) |
| Mar 2013 | - | -$317.86M(+6.5%) |
| Dec 2012 | -$298.57M(+21.9%) | -$298.57M(+1.5%) |
| Sep 2012 | - | -$294.17M(+7.3%) |
| Jun 2012 | - | -$274.16M(+5.4%) |
| Mar 2012 | - | -$260.14M(+6.2%) |
| Dec 2011 | -$245.02M(+8.8%) | -$245.02M(+8.1%) |
| Sep 2011 | - | -$226.61M(-2.2%) |
| Jun 2011 | - | -$231.77M(-1.3%) |
| Mar 2011 | - | -$234.89M(+4.3%) |
| Dec 2010 | -$225.25M(+31.0%) | -$225.25M(+8.1%) |
| Sep 2010 | - | -$208.36M(+6.3%) |
| Jun 2010 | - | -$195.95M(+6.6%) |
| Mar 2010 | - | -$183.80M(+6.9%) |
| Dec 2009 | -$172.01M(+51.4%) | -$172.01M(+7.9%) |
| Sep 2009 | - | -$159.35M(+9.6%) |
| Jun 2009 | - | -$145.44M(+13.3%) |
| Mar 2009 | - | -$128.38M(+13.0%) |
| Dec 2008 | -$113.65M(+74.9%) | -$113.65M(+17.4%) |
| Sep 2008 | - | -$96.82M(+12.6%) |
| Jun 2008 | - | -$85.95M(+14.7%) |
| Mar 2008 | - | -$74.95M(+15.3%) |
| Dec 2007 | -$65.00M(+58.1%) | -$65.00M(+15.5%) |
| Sep 2007 | - | -$56.29M(+14.3%) |
| Jun 2007 | - | -$49.26M(+10.8%) |
| Mar 2007 | - | -$44.46M(+8.2%) |
| Dec 2006 | -$41.10M(+56.0%) | -$41.10M(+11.9%) |
| Sep 2006 | - | -$36.72M(+11.0%) |
| Jun 2006 | - | -$33.07M(+10.8%) |
| Mar 2006 | - | -$29.84M(+13.2%) |
| Dec 2005 | -$26.35M(+101.6%) | -$26.35M(+15.4%) |
| Sep 2005 | - | -$22.83M(+19.3%) |
| Jun 2005 | - | -$19.13M(+17.6%) |
| Mar 2005 | - | -$16.27M(+24.4%) |
| Dec 2004 | -$13.07M(>+9900.0%) | -$13.07M(+23.4%) |
| Sep 2004 | - | -$10.59M(+44.3%) |
| Jun 2004 | - | -$7.34M(+39.4%) |
| Mar 2004 | - | -$5.26M(+3946.8%) |
| Sep 2003 | - | -$130.10K(+7.9%) |
| Jun 2003 | - | -$120.60K(+5.1%) |
| Mar 2003 | - | -$114.80K(+94.6%) |
| Sep 2002 | - | -$59.00K(+27.2%) |
| Jun 2002 | - | -$46.40K(+53.1%) |
| Mar 2002 | - | -$30.30K |
| Dec 2001 | -$39.70K | - |
FAQ
- What is Halozyme Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual retained earnings year-on-year change?
- What is Halozyme Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly retained earnings year-on-year change?
What is Halozyme Therapeutics annual retained earnings?
The current annual retained earnings of HALO is $359.87M
What is the all time high annual retained earnings for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual retained earnings is $359.87M
What is Halozyme Therapeutics annual retained earnings year-on-year change?
Over the past year, HALO annual retained earnings has changed by +$269.32M (+297.43%)
What is Halozyme Therapeutics quarterly retained earnings?
The current quarterly retained earnings of HALO is $477.96M
What is the all time high quarterly retained earnings for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly retained earnings is $477.96M
What is Halozyme Therapeutics quarterly retained earnings year-on-year change?
Over the past year, HALO quarterly retained earnings has changed by +$310.59M (+185.57%)